| 000 | 01685 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516231056.0 | ||
| 264 | 0 | _c20150810 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1471-1788 | ||
| 024 | 7 |
_a10.3109/13651501.2014.957705 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMa, Xiaojie | |
| 245 | 0 | 0 |
_aHTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis. _h[electronic resource] |
| 260 |
_bInternational journal of psychiatry in clinical practice _cOct 2014 |
||
| 300 |
_a229-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBenzodiazepines _xadverse effects |
| 650 | 0 | 4 |
_aClozapine _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Association Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xchemically induced |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT2C _xgenetics |
| 650 | 0 | 4 |
_aRisperidone _xadverse effects |
| 650 | 0 | 4 |
_aSchizophrenia _xcomplications |
| 650 | 0 | 4 |
_aWeight Gain _xdrug effects |
| 700 | 1 | _aMaimaitirexiati, Tuerxun | |
| 700 | 1 | _aZhang, Rong | |
| 700 | 1 | _aGui, Xueping | |
| 700 | 1 | _aZhang, Wenhui | |
| 700 | 1 | _aXu, Guozheng | |
| 700 | 1 | _aHu, Gang | |
| 773 | 0 |
_tInternational journal of psychiatry in clinical practice _gvol. 18 _gno. 4 _gp. 229-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/13651501.2014.957705 _zAvailable from publisher's website |
| 999 |
_c24125428 _d24125428 |
||